Strumento inattivo

Azioni Corium International Inc

Azioni

Durata

Periodo

Stile

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease	27/01/20
Corium Appoints Perry Sternberg as Chief Executive Officer	02/04/19
Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025	17/12/18
Corium International : RM LAW Announces Investigation of Corium International, Inc.	15/10/18
Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares	11/10/18

Dirigenti	Titolo	Età	Da
Perry Sternberg CEO	Chief Executive Officer	55	01/04/19
John Miller DFI	Director of Finance/CFO	-	-
Charles Oh CTO	Chief Tech/Sci/R&D Officer	-	-

Amministratori	Titolo	Età	Da
Brooks William Andrews BRD	Director/Board Member	-	-
David S. Moore BRD	Director/Board Member	50	-
Perry Sternberg		55	-

Settore